Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
Leah Hunter Commissioner for External Affairs (OEA) within the Office of the Commissioner at the U.S. Food and Drug Administration | Official Website
This is an increase over the number of companies cited in the previous year.
The citations in the county include:
- You did not identify and implement preventive controls to ensure that any hazards requiring a preventive control are significantly minimized or prevented.
- Representative samples are not taken of each shipment of each lot of drug product containers and closures for testing or examination.
- Your firm failed to establish written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
Chief Ethanol Fuels, Inc. | Veterinary | 06/14/2023 | Preventive Controls |
EPM Packaging, Inc. | Drugs | 01/12/2023 | Representative Samples |
EPM Packaging, Inc. | Drugs | 01/12/2023 | Absence of Written Procedures |
EPM Packaging, Inc. | Drugs | 01/12/2023 | In-Process and Laboratory Control Results |